CAS RN: 132-69-4
Benzydamine Hydrochloride
Product Availability
Choose a grade to view its available package options.
2 package records 2 with current stock 2 grade groups
Grade
10 mM in DMSO (1)
98% (1)
In stock only
Batch No. Package Availability Warehouse Inquiry
Batchno.20251008
1ml
In stock
Inquiry
Batch No. Package Availability Warehouse Inquiry
Batchno.20250608
1g / 5g / 25g / 100g / 500g
Confirm by inquiry
Shanghai, Shandong, Chongqing Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 100g
Available purity: >97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 132-69-4
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
100g
>97%
0
Out of Stock
Beijing
Inquiry
132-69-4 / 3-(1-benzylindazol-3-yl)oxy-N,N-dimethylpropan-1-amine;hydrochloride
Standard CAS: 132-69-4
Multi CAS: No
Basic Information
copy
CAS
132-69-4 copy
Multi CAS
No copy
Molecular Formula
C19H24ClN3O copy
Molecular Weight
345.900000 copy
Exact Mass
345.160790 copy
SMILES
CN(C)CCCOC1=NN(C2=CC=CC=C21)CC3=CC=CC=C3.Cl copy
InChI
InChI=1S/C19H23N3O.ClH/c1-21(2)13-8-14-23-19-17-11-6-7-12-18(17)22(20-19)15-16-9-4-3-5-10-16;/h3-7,9-12H,8,13-15H2,1-2H3;1H copy
InChIKey
HNNIWKQLJSNAEQ-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
24 copy
Aromatic heavy atom count
15 copy
Fraction Csp3
0.32 copy
Rotatable bonds
7 copy
H-bond acceptors
4 copy
H-bond donors
1 copy
Molar refractivity
101.19 copy
TPSA
30.29 copy
LogP / Solubility
WLOGP
3.84 copy
MLOGP
3.39 copy
XLogP3
3.84 copy
Consensus LogP
3.69 copy
Log S (ESOL)
-4.4 copy
Class (ESOL)
Slightly soluble copy
Log S (Ali)
-5.17 copy
Class (Ali)
Slightly soluble copy
Log S (SILICOS-IT)
-5.93 copy
Class (SILICOS-IT)
Slightly soluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
Yes copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.11 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
2.5 copy
Safety & Transport
copy
Pictogram(s)
Irritant copy
Signal
Warning copy
GHS Hazard Statements
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
H319 (98.1%): Causes serious eye irritation [Warning Serious eye damage/eye irritation] copy
Precautionary Statement Codes
P264, P264+P265, P270, P280, P301+P317, P305+P351+P338, P330, P337+P317, and P501 copy